Vimarsana
Biggest News Aggregation in the World

Page 7 - Briggs Morrison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Briggs Morrison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Briggs Morrison Today - Breaking & Trending Today

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading 8.6% Higher - Vimarsana News

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading 8.6% Higher

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating)’s stock price traded up 8.6% during trading on Tuesday . The company traded as high as $22.67 and last traded at $22.53. 576,831 shares traded hands during trading, a decline of 32% from the average session volume of 842,487 shares. The stock had previously closed at $20.74. Analyst […]

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Director Sells $1,119,468.90 in Stock - Vimarsana News

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Director Sells $1,119,468.90 in Stock

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) Director Briggs Morrison sold 52,855 shares of the stock in a transaction on Friday, June 9th. The stock was sold at an average price of $21.18, for a total value of $1,119,468.90. Following the completion of the transaction, the director now directly owns 17,836 shares of the company’s […]

683 Capital Management LLC Has $14.51 Million Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Vimarsana News

683 Capital Management LLC Has $14.51 Million Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

683 Capital Management LLC reduced its stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) by 49.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 570,000 shares of the company’s stock after selling 560,000 shares during the period. Syndax […]

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $33.86 Average Price Target from Brokerages - Vimarsana News

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $33.86 Average Price Target from Brokerages

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) have earned an average rating of “Moderate Buy” from the eight research firms that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among […]

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Down 3.6% - Vimarsana News

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Down 3.6%

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating)’s share price was down 3.6% during mid-day trading on Wednesday . The stock traded as low as $20.83 and last traded at $20.92. Approximately 170,399 shares were traded during trading, a decline of 80% from the average daily volume of 844,999 shares. The stock had previously closed at […]